Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC, commonly known as MSD, is a leading global healthcare company headquartered in the United States. Founded in 1891, MSD has established a strong presence in various operational regions, including Europe, Asia, and Latin America, focusing on innovative pharmaceuticals, vaccines, and animal health products. With a commitment to research and development, MSD is renowned for its core offerings, which include groundbreaking treatments in oncology, infectious diseases, and vaccines. The company has achieved significant milestones, such as the development of key therapies that have transformed patient care. Recognised for its robust market position, MSD continues to be a pioneer in the pharmaceutical industry, driven by a mission to improve health outcomes worldwide.
DitchCarbon Score
How does Merck Sharp & Dohme LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Merck Sharp & Dohme LLC's score of 50 is higher than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Merck Sharp & Dohme LLC's reported carbon emissions
In 2018, Merck Sharp & Dohme LLC reported Scope 2 emissions of approximately 245.3 kg CO2e, reflecting their energy consumption from purchased electricity. The company has set ambitious climate commitments, aiming to achieve carbon neutrality across its operations (Scopes 1 and 2) by 2025. This target is part of a broader strategy to reduce absolute greenhouse gas emissions by 46% by 2030 from a 2019 baseline, which includes biogenic emissions and removals from bioenergy feedstocks. Additionally, Merck Sharp & Dohme LLC has committed to reducing greenhouse gas emissions by at least 40% from 2015 levels by 2025, in accordance with the GHG Protocol for Scope 1 and market-based Scope 2 emissions. These targets are cascaded from their parent company, Merck & Co., Inc., which oversees their sustainability initiatives. Overall, Merck Sharp & Dohme LLC is actively working towards significant emissions reductions and climate resilience, aligning with industry standards and best practices in environmental sustainability.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | |
|---|---|
| Scope 1 | - |
| Scope 2 | 245.3 |
| Scope 3 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Merck Sharp & Dohme LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
